Jan 8 (Reuters) - Alder Biopharmaceuticals Inc:
* ALDER ANNOUNCES $250 MILLION COMMITTED EQUITY FINANCING * ALDER BIOPHARMACEUTICALS INC - INVESTORS TO PURCHASE UP TO $250 MILLION OF NON-VOTING CLASS A PREFERRED STOCK DURING 3-YEAR TERM OF AGREEMENT
* ALDER BIOPHARMACEUTICALS INC - TO USE NET PROCEEDS TO FUND PAYMENTS UNDER ALDERâ€˜S EUROPEAN PATENT SETTLEMENT
* ALDER BIOPHARMACEUTICALS INC - TO ALSO USE PROCEEDS FOR EPTINEZUMAB INFUSION COMMERCIALIZATION-READINESS ACTIVITIES Source text for Eikon: Further company coverage:
 